NEW YORK, Nov. 13 — Geneka Biotechnology will be opening an office in Strasbourg, France, toward the start of the new year, the company announced on Tuesday.
The new office, which represents the company’s first international expansion, will be small at first and will have no associated lab space, said Jean Rousseau, director of international marketing and sales at Montreal-based Geneka.
The company chose Strasbourg for its central location and proximity to Germany, Switzerland, and the Alsace region in western France, where a lot of important research into transcription factors is carried out, added Rousseau.
“The concentration of the market is there for us,” he said.
Geneka, which focuses on proteomic regulators, including transcription factors, co-activators, co-repressors, and chromatin associated proteins, will be recruiting locally to fill the new office.